AI
DXCM icon

Analytic Investors’s DexCom DXCM Stock Holding History

Analytic Investors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-393,064
Closed -$8.05M – 624
2015
Q4 		$8.05M Sell
393,064
-55,524
-12% -$1.16M 0.1% 171
2015
Q3 		$9.63M Buy
448,588
+295,492
+193% +$6.59M 0.13% 149
2015
Q2 		$3.06M Buy
+153,096
New +$2.69M 0.04% 230

Other funds holding DXCM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Analytic Investors's DXCM Position: Q1 2016 in Review

Analytic Investors sold out of DexCom (DXCM) in Q1 2016, closing a stake of 393,064 shares — an estimated $8.05M sold.

Analytic Investors first reported a position in DXCM in Q2 2015 and held it in 3 quarters. The position peaked at $9.63M in Q3 2015. 264 funds tracked by Wall St. Rank hold DXCM as of Q1 2016.

  • Analytic Investors reported no remaining DexCom position as of Q1 2016 after selling out during the quarter.
  • Analytic Investors sold 393,064 DexCom shares in Q1 2016, an estimated $8.05M.
  • Analytic Investors first reported a position in DexCom in Q2 2015 and held it in 3 quarters.
  • Analytic Investors's DexCom position peaked at $9.63M in Q3 2015.
  • 264 funds tracked by Wall St. Rank held DexCom as of Q1 2016.

Based on Analytic Investors's 13F filing for Q1 2016, filed 20 May 2016.